Silo Pharma, Inc. (SILO)
1.458
-0.04
(-2.80%)
USD |
NASDAQ |
Oct 02, 16:00
1.21
-0.25
(-17.01%)
After-Hours: 20:00
Silo Pharma Price to Book Value : 0.3368 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.3368 |
| October 01, 2026 | 0.3465 |
| September 30, 2026 | 0.3488 |
| September 29, 2026 | 0.3719 |
| September 28, 2026 | 0.3811 |
| September 25, 2026 | 0.4042 |
| September 24, 2026 | 0.4042 |
| September 23, 2026 | 0.4088 |
| September 22, 2026 | 0.3973 |
| September 21, 2026 | 0.403 |
| September 18, 2026 | 0.425 |
| September 17, 2026 | 0.3973 |
| September 16, 2026 | 0.4065 |
| September 15, 2026 | 0.4481 |
| September 14, 2026 | 0.4781 |
| September 11, 2026 | 0.485 |
| September 10, 2026 | 0.486 |
| September 09, 2026 | 0.4966 |
| September 08, 2026 | 0.5266 |
| September 04, 2026 | 0.5543 |
| September 03, 2026 | 0.5659 |
| September 02, 2026 | 0.5774 |
| September 01, 2026 | 0.5636 |
| August 31, 2026 | 0.5728 |
| August 28, 2026 | 0.5867 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.5867 |
| August 26, 2026 | 0.5774 |
| August 25, 2026 | 0.5982 |
| August 24, 2026 | 0.5959 |
| August 21, 2026 | 0.6121 |
| August 20, 2026 | 0.6329 |
| August 19, 2026 | 0.6606 |
| August 18, 2026 | 0.7091 |
| August 17, 2026 | 0.7091 |
| August 14, 2026 | 0.7391 |
| August 13, 2026 | 0.7437 |
| August 12, 2026 | 0.7149 |
| August 11, 2026 | 0.8223 |
| August 10, 2026 | 0.8731 |
| August 07, 2026 | 0.8627 |
| August 06, 2026 | 1.079 |
| August 05, 2026 | 1.065 |
| August 04, 2026 | 1.062 |
| August 03, 2026 | 0.9978 |
| July 31, 2026 | 0.9678 |
| July 30, 2026 | 0.9816 |
| July 29, 2026 | 0.9932 |
| July 28, 2026 | 1.030 |
| July 27, 2026 | 1.016 |
| July 24, 2026 | 1.032 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
| Biogen, Inc. | 1.723 |
Price to Book Value Related Metrics
| PS Ratio | 23.73 |
| Price | 1.458 |
| Earnings Yield | -366.1% |
| Market Cap | 1.646M |